These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 910982)

  • 21. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lofepramine: a comparative clinical study with amitriptyline].
    Mariategui J; Chávez H; Olivares A
    Acta Physiol Lat Am; 1978 Sep; 24(3):201-9. PubMed ID: 375679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M; Devoitille JM; Papart P; Vanbrabant E; Mantanus H; Timsit-Berthier M
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
    Wheatley D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.
    Rampello L; Alvano A; Chiechio S; Malaguarnera M; Raffaele R; Vecchio I; Nicoletti F
    Neuropsychobiology; 2004; 50(4):322-8. PubMed ID: 15539864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism].
    Gembicki M; Sobieszczyk S; Kosowicz J
    Endokrynol Pol; 1979; 30(2):155-61. PubMed ID: 467382
    [No Abstract]   [Full Text] [Related]  

  • 29. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid functioning during treatment for depression.
    Kusalic M; Engelsmann F; Bradwejn J
    J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
    Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
    J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
    Bird H; Broggini M
    J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-dopa stimulation at growth hormone release in normal subjects and in patients with Sheehan's syndrome.
    Himathongkam T; Tiyapan A; Rajatanavin R; Pitchayayothin N
    J Med Assoc Thai; 1981 Jan; 64(1):19-25. PubMed ID: 7217816
    [No Abstract]   [Full Text] [Related]  

  • 36. [Doxepin, a new antidepressant: comparison of effects with amitriptyline].
    Bauer G; Nowak H
    Arzneimittelforschung; 1969 Oct; 19(10):1642-6. PubMed ID: 4902490
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of phenelzine and amitriptyline on depression [proceedings].
    Paykel ES; Rowan PR; Parker RR
    Psychopharmacol Bull; 1981 Jan; 17(1):104-6. PubMed ID: 7232635
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy of psychotherapy in depression: symptom remission and response to treatment.
    Weissman MM; Klerman GL; Prusoff BA; Hanson B; Paykel ES
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):165-77. PubMed ID: 772672
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of depression in the medically ill geriatric patient: a case report.
    Dunn CG; Gross D
    Am J Psychiatry; 1977 Apr; 134(4):448-50. PubMed ID: 842740
    [No Abstract]   [Full Text] [Related]  

  • 40. [Controlled trial of amitriptyline in a group of patients with so-called functional pseudorheumatic pain].
    Limon J; Paolaggi JB; Debray Q; Auquier L
    Presse Med; 1985 Nov; 14(41):2107. PubMed ID: 2934715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.